Shin Nippon Biomedical Laboratories to sell unit for 1 bln yen
Aug 31(Reuters) - Shin Nippon Biomedical Laboratories Ltd <2395.T>:Says it plans to sell 100 percent voting power in unit Shin Nippon Biomedical Laboratories SMO, Ltd., for 1 billion yen, to M3 Inc <<<2413.T>>>.Transaction date on Oct. 1.
Latest Key Developments inBiotechnology
- Tonix Pharma Says Breakthrough Therapy Status Remains In Effect For Posttraumatic Stress Disorder Treatment Tonmya
- Cyclerion Therapeutics Files For Offering Of Up To 11.55 Mln Shares Of Common Stock By The Selling Stockholders
- Seres Therapeutics Says Board Appointed Marcus Chapman As Principal Financial And Accounting Officer
- Prothena Reports Results From The Phase 3 Vital Amyloidosis Study Of Neod001 In Al Amyloidosis